2LS vs LCLA: Side-by-Side Comparison
Compare SILOAM INTL HOS. RP 125 (2LS) and PT Kalbe Farma Tbk (LCLA) side by side: market cap EUR 1.25B vs EUR 2.13B. Financials, growth and model signals on Bullrun.
| Metric | 2LS | LCLA |
|---|---|---|
| Company | SILOAM INTL HOS. RP 125 | PT Kalbe Farma Tbk |
| Country / Exchange | Indonesia · F | Indonesia · F |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Drug Manufacturers - General |
| Market cap | EUR 1.25B | EUR 2.13B |
| P/E ratio | — | — |
| Dividend yield | — | 2.93% |
| Valuation model | — | — |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |